5Lee W H,Morton R A,Epstein J I,et al. Cytidine Methylation of Regulatory Sequences Near the Pi-class Glutathione S-transferase Gene Accompanies Human Prostatic Careinogenesis[J]. Proc Natl Acad Sci USA,1994,91(24):11733-11737.
6Katoh T,Yamano Y,Tsuji M,et al. Genetic Polymorphisms of Human Cytosol Glutathione S-transferases and Prostate Cancer[J]. Pharmacogenomics, 2008,9 ( 1 ) : 93-104.
7Kekeeva T V,Popova O P,Shegai P V,et al. Abberant Methylation of p16, HIC1, N33 and GSTP1 Genes in Tumor Epitelium and Tumor-associated Stromal Cells of Prostate Cancer[J].Mol Biol (Mosk) ,2007,41(1) :79-85.
8Henrique R, Jeronimo C. Molecular Detection of Prostate Cancer:A Role for GSTP1 Hypermethylation[J]. Eur Urol, 2004,46 (5) : 660-669.
9Vener T, Derecho C, Baden J, et al. Developement of a Multiplexed Urine Assay for Prostate Cancer Diagnosis[J]. Clin Chem, 2008,54 (5) : 874-882.
10Bastian P J, Palapattu G S, Yegnasubramanian S, et al. CpG Island Hypermethylation Profile in The Serum of Men with Clinically Localized and Hormone Refractory Metastatic Prostate Cancer[J]. J Urol,2008,179(2) :529-534.
二级参考文献15
1Merlo A, Herman JG, Mao L, et al. 5 'CpG island methylation is associated with transcription silencing of the tumor suppressor pl6/CDKN2/MTS1 in human cancers[J]. Nat Med,1995,1 (7) :686-692.
2Boltze C, Zack S, Quednow C,et al. Hypermethylation of the CDKN2/pl61NK4A promotor in thyroid carcinogenesis [J]. Pathol Res Pract,2003,199 ( 6 ) : 399 -404.
3Schagdarsuregin U, Gimm O, Cuong Hoang-Vu C, et al. Frequent epigenetic silencing of the CpG island promoter of RASSF1 A in thyroid carcinoma[J]. Cancer Res ,2002.62 ( 12 ):3698-3701.
4Xing M, Cohen Y, Mambo E, et al. Early ocurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesis[ J ]. Cancer Res ,2004,64 ( 6 ) : 1664-1668.
5Graft JR, Greenberg VE, Herman JG,et al. Distinct patterns of Ecadherin CpG island methylation in papillary, follicular, Hurthle's cell, and poorly differentiated human thyroid carcinoma[ J]. Cancer Res, 1998,58 ( 10 ) :2063-2066.
6Maass N, Hojo T,Ueding M,et al. Expression of the tumor suppressor gene Maspin in human pancreatic cancers[J]. Clin Cancer Res,2001,7(4) :812-817.
7Sood AK, Fletcher MS, Gruman LM, et al. The paradoxical expression of Maspin in ovarian carcinoma [ J ]. Clin Cancer Res, 2002,8( 9 ) :2924-2932.
8Futscher BW, Oshiro MM, Wozniak R J, et al. Role for DNA methylation in the control of cell type specific maspin expression [J]. Nat Genet,2002,31 (2) : 175-179.
9Ogasawara S, Maesawa C, Yamamoto M, et al. Disruption of cell-type-specific methylation at the Maspin gene promoter is frequently involved in undifferentiated thyroid cancers[J]. Oncogene,2004,23(5) :1117-1124.
10Gopalakrishnan M, Venkataraman M, Yatin M, et al. Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na^+/I^- symporter gene methylation status[J]. J Clin Endocrinol Metab ,1999,84 (7) :2449-2457.
